Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Paul W. Sperduto(Methodist Hospital), Minesh P. Mehta(Columbia University), David Roberge(Centre Hospitalier de l’Université de Montréal), Amanda Schwer(University of Colorado Denver), Amit Bhatt(Apple (Israel)), Penny K. Sneed(University of California, San Francisco), Helen A. Shih(Massachusetts General Hospital), Jonathan Knisely(Apple (Israel)), Veronica Chiang(Yale University), Samuel T. Chao(Cleveland Clinic), Paul D. Brown(Mayo Clinic), John H. Suh(Cleveland Clinic), John P. Kirkpatrick(Duke University), John B. Fiveash(University of Alabama at Birmingham), Laurie E. Gaspar(University of Colorado Cancer Center), Christina Maria Sperduto(Dartmouth College), Ashley W. Jensen(Apple (Israel)), Xianghua Luo(Apple (Israel))
International Journal of Radiation Oncology*Biology*Physics
November 28, 2009
Cited by 984
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k